These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15767551

  • 1. A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3.
    Jimenez X, Lu D, Brennan L, Persaud K, Liu M, Miao H, Witte L, Zhu Z.
    Mol Cancer Ther; 2005 Mar; 4(3):427-34. PubMed ID: 15767551
    [Abstract] [Full Text] [Related]

  • 2. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
    Lu D, Shen J, Vil MD, Zhang H, Jimenez X, Bohlen P, Witte L, Zhu Z.
    J Biol Chem; 2003 Oct 31; 278(44):43496-507. PubMed ID: 12917408
    [Abstract] [Full Text] [Related]

  • 3. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y, Zhang X, Simons M.
    Arterioscler Thromb Vasc Biol; 2015 Feb 31; 35(2):421-9. PubMed ID: 25524775
    [Abstract] [Full Text] [Related]

  • 4. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
    Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Kussie P, Koo H, Kim HJ, Lu D, Liu M, Tejada R, Friedrich M, Bohlen P, Witte L, Rafii S.
    Leukemia; 2003 Mar 01; 17(3):604-11. PubMed ID: 12646950
    [Abstract] [Full Text] [Related]

  • 6. Bispecific single-chain diabody-mediated killing of endoglin-positive endothelial cells by cytotoxic T lymphocytes.
    Korn T, Müller R, Kontermann RE.
    J Immunother; 2004 Mar 01; 27(2):99-106. PubMed ID: 14770081
    [Abstract] [Full Text] [Related]

  • 7. Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.
    Persaud K, Tille JC, Liu M, Zhu Z, Jimenez X, Pereira DS, Miao HQ, Brennan LA, Witte L, Pepper MS, Pytowski B.
    J Cell Sci; 2004 Jun 01; 117(Pt 13):2745-56. PubMed ID: 15150322
    [Abstract] [Full Text] [Related]

  • 8. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.
    Lu D, Jimenez X, Zhang H, Bohlen P, Witte L, Zhu Z.
    Int J Cancer; 2002 Jan 20; 97(3):393-9. PubMed ID: 11774295
    [Abstract] [Full Text] [Related]

  • 9. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K, Karaman S, D'Amico G, Tammela T, Sormunen R, Eklund L, Alitalo K, Zarkada G.
    Circ Res; 2017 Apr 28; 120(9):1414-1425. PubMed ID: 28298294
    [Abstract] [Full Text] [Related]

  • 10. A novel bispecific diabody targeting both vascular endothelial growth factor receptor 2 and epidermal growth factor receptor for enhanced antitumor activity.
    Xu M, Jin H, Chen Z, Xie W, Wang Y, Wang Y, Wang M, Zhang J, Acheampong DO.
    Biotechnol Prog; 2016 Mar 28; 32(2):294-302. PubMed ID: 26785424
    [Abstract] [Full Text] [Related]

  • 11. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, Wise L, Mercer A, Kowalski H, Kerjaschki D, Stacker SA, Achen MG, Alitalo K.
    EMBO J; 2001 Sep 03; 20(17):4762-73. PubMed ID: 11532940
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.
    Zhang H, Li Y, Li H, Bassi R, Jimenez X, Witte L, Bohlen P, Hicklin D, Zhu Z.
    Leuk Lymphoma; 2004 Sep 03; 45(9):1887-97. PubMed ID: 15223651
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor-C promotes human mesenchymal stem cell migration via an ERK-and FAK-dependent mechanism.
    Ishii M, Takahashi M, Murakami J, Yanagisawa T, Nishimura M.
    Mol Cell Biochem; 2019 May 03; 455(1-2):185-193. PubMed ID: 30443854
    [Abstract] [Full Text] [Related]

  • 14. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor.
    Wong C, Jin ZG.
    J Biol Chem; 2005 Sep 30; 280(39):33262-9. PubMed ID: 16006559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Wedge SR, Jürgensmeier JM, Alitalo K.
    Cancer Res; 2008 Jun 15; 68(12):4754-62. PubMed ID: 18559522
    [Abstract] [Full Text] [Related]

  • 17. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T, Toivanen PI, Rintanen N, Heikura T, Jauhiainen S, Airenne KJ, Alitalo K, Marjomäki V, Ylä-Herttuala S.
    Biochim Biophys Acta; 2014 Jan 15; 1840(1):454-63. PubMed ID: 24112971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor-C induces osteogenic differentiation of human mesenchymal stem cells through the ERK and RUNX2 pathway.
    Murakami J, Ishii M, Suehiro F, Ishihata K, Nakamura N, Nishimura M.
    Biochem Biophys Res Commun; 2017 Mar 11; 484(3):710-718. PubMed ID: 28163024
    [Abstract] [Full Text] [Related]

  • 20. Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF.
    Masson-Gadais B, Houle F, Laferrière J, Huot J.
    Cell Stress Chaperones; 2003 Mar 11; 8(1):37-52. PubMed ID: 12820653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.